Genoks Genetics Center started their next-generation sequencing (NGS) business in 2011, in Ankara, Türkiye. In 2021, Genoks Managing Director, Eren Akdeniz and his team made the switch to Illumina NGS, introducing the MiSeq™, NextSeq™ 550Dx*, and NovaSeq™ 6000. With increased reliability and rapid turnaround times Genoks has been able to scale their service and position themselves a leader in their market. Learn more about Illumina sequencing platforms: https://www.illumina.com/systems/sequencing-platforms.html *For In Vitro Diagnostic Use. Not available in all countries or regions. Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM Facebook: https://www.facebook.com/illuminainc LinkedIn: https://www.linkedin.com/company/illumina Instagram: https://www.instagram.com/illuminainc/ Twitter: https://twitter.com/illumina